1 Multiple lines of evidence indicate that CD8 + T cells are important in the control of HIV-1 2 (HIV) replication. However, CD8 + T cells induced by natural infection cannot eliminate the virus 3 or reduce viral loads to acceptably low levels in most infected individuals. Understanding the 4 basic quantitative features of CD8 + T-cell responses induced during the course of HIV infection 5 may therefore inform us about the limits that HIV vaccines, which aim to induce protective CD8 + 6 T-cell responses, must exceed. Using previously published experimental data from a cohort of HIV-7 infected individuals with sampling times from acute to chronic infection we defined the quantitative 8 properties of CD8 + T-cell responses to the whole HIV proteome. In contrast with a commonly 9 held view, we found that the relative number of HIV-specific CD8 + T-cell responses (response 10 breadth) changed little over the course of infection (first 400 days post-infection), with moderate 11 but statistically significant changes occurring only during the first 35 symptomatic days. This 12 challenges the idea that a change in the T-cell response breadth over time is responsible for the slow 13 speed of viral escape from CD8 + T cells in the chronic infection. The breadth of HIV-specific CD8 + 14 T-cell responses was not correlated with the average viral load for our small cohort of patients, 15 highlighting the possibility that statistically significant correlations previously found in other small 16 cohorts of patients arose by chance. Metrics of relative immunodominance of HIV-specific CD8 + T-17 cell responses such as Shannon entropy or the Evenness index were also not significantly correlated 18 with the average viral load. Our mathematical-model-driven analysis suggested extremely slow 19 expansion kinetics for the majority of HIV-specific CD8 + T-cell responses and the presence of 20 intra-and interclonal competition between multiple CD8 + T-cell responses; such competition 21 may limit the magnitude of CD8 + T-cell responses, specific to different epitopes, and the overall 22 number of T-cell responses induced by vaccination. Together, our results suggest that vaccines 23 inducing T-cell responses with breadth and expansion kinetics similar to those induced by natural 24 HIV infection are unlikely to be highly efficacious, and we propose minimum quantitative features 25 of CD8 + T-cell responses (breadth, expansion kinetics) that vaccines must induce to be deemed 26 acceptable for further testing.
Introduction
with E(0) = E 0 as the predicted initial frequency of epitope-specific CD8 + T cells at time t = 0 126 days since symptom onset. 127 Figure 1 : Schematic representation of the T on /T off mathematical model fitted to the epitope-specific CD8 + T-cell response kinetics data [86] . In this model, E 0 epitope-specific naive CD8 + T cells become activated at time t = T on and start proliferating at rate ρ. At t = T off , T cell response peaks and declines at rate α. We refer to E 0 as the predicted initial frequency of epitope-specific CD8 + T cells [87] . Evidently, E 0 may over-or under-estimate the response precursor frequency depending on exactly when the T cells became activated and how adequate the mathematical model is for describing immune response data during the expansion phase.
Most immune responses (about 80%) had a detectable frequency at the first time point at which Most HIV proteins were recognized by CD8 + T cell responses. We calculated the frequency at which HIV proteins were recognized by CD8 + T cells; overall, 50% of responses were directed against Env or Gag (A). m = 8 CD8 + T cell responses were detected in this cohort of 22 patients at any given time point after infection (B) . In B (and other figures in the paper), µ denotes the average, m is the median, and σ is the standard deviation. The distributions are shown for the first 100 days after symptom onset but, overall, distributions changed little over the course of 400 days of infection (results not shown). Patient SUMA0874 was excluded from the analysis in B due to a lack of measurements of all T cell responses at all time points. Figure 3 : Modest yet statistically significant increase in the average normalized T-cell response breadth over the course of the first year of HIV infection. We divided the observations into different time bins (A, 50-day intervals; B, 100-day intervals) and calculated the relative breadth for the corresponding interval. The relative breadth was calculated as the number of HIV-specific CD8 + T-cell responses detected in a given time period divided by the number of all responses measured for that patient in all time periods; data were averaged to simplify presentation. Averaging did not influence the statistical significance of conclusions (not shown). Colors and symbols represent the data from different patients as shown in Fig. S5 in Supplementary Material. Black horizontal bars denote the mean relative breadth for that time interval for all patients. There was a statistically significant increase in relative breadth (Spearman's rank correlation coefficient ρ and p values indicated on panels). There was no change in the average total immune response in all patients (Fig. S6 ). Detailed analysis of the relative number of CD8 + T-cell responses in individual patients revealed variable patterns: constant breadth, increasing breadth, decreasing breadth, and breadth changing non-monotonically over time ( Fig. S7 ). Also, no overall change in the average breadth (un-normalized) was observed ( Fig. S5 ). We observed a similarly modest but significant increase in SE and EI of HIV-specific CD8 + T-cell response with time ( Fig. S8 ).
immunodominance (or richness): Shannon entropy (SE) and Evenness index (EI, see Materials

254
and Methods for details). While SE has been used to measure HIV genome variability in sequence 255 alignments, it has not previously been used to estimate immunodominance of immune responses.
256
Our analysis suggested that both SE and EI increased over the course of infection and that 257 this change was more significant for EI, in part because EI cannot exceed 1 by definition (Figs.
258
S8-S10). However, the statistically significant increases in these two metrics were also mainly 259 restricted to the first 40 days since symptom onset (not shown). Thus, the number and magnitude 260 of evenness for HIV-specific CD8 + T cell responses both appear to increase very early in infection 261 and stabilize within 40 days of symptom onset. Correlates of protection against disease progression of HIV-infected individuals are incompletely 265 understood. It is well known that viral load is strongly correlated with risk of disease progression 266 in HIV-infected patients [95] and many other parameters have been measured to reveal potential 267 markers of protection. Among these, the breadth of HIV-specific CD8 + T-cell response has been 268 widely emphasized as a potential predictor of viral control. Several studies found a statistically 269 significant negative correlation between the number of Gag-specific CD8 + T-cell responses and 270 viral load [33, 34, 36, 91, 96] whereas others did not [32] . In some of these studies, statistically significant negative correlations were based on relatively small numbers of patients, e.g., n = 18 272 in Radebe et al. [91] . A negative correlation between viral load and breadth of Gag-specific CD8 + 273 T-cell responses was also found using bioinformatic predictions of potential T cell epitopes [35] .
274
Negative correlations between viral load and CD8 + T-cell response breadth have generally been 275 interpreted as an indication of protection even though it has been shown that viral load has an 276 impact on the change in the number of Gag-specific T-cell responses over time [97] . Figure 4 : Breadth of HIV-specific CD8 + T-cell response in a patient does not correlate significantly with average viral load. We calculated the average number of HIV-specific (A-C), Gag-specific (D-F), and Env-specific (G-I) CD8 + T-cell responses over the whole observation period (A, D, G), during acute infection (t ≤ 100 days since symptom onset; B, E, H), or during chronic infection (t > 100 days since symptom onset; C, F, I) and log 10 average viral load in that time period. The average viral load during infection was not dependent on the breadth of the Gag-specific CD8 + T-cell response during the infection (D-F). Patient SUMA0874 was excluded from the analysis in A-C due to insufficient measurements of all T-cell responses at all time points.
We investigated the relationship between three different metrics of T-cell response efficacy: 278 breadth, SE, and EI (see Material and Methods) . For that, we calculated the average viral load 279 and average metric for the whole observation period in a patient, during the acute (t ≤ 100 days 280 since symptoms) or chronic (t > 100 days) phase of infection. None of the correlations between 281 metric and viral load were significant, independent of the time period of infection or protein 282 specificity (Figs. 4 and S11). 283 We also investigated whether changes in the immune response breadth over time were nega-284 tively correlated with viral load. Because there was a statistically significant increase in breadth 285 within the first month of symptom onset, a negative correlation between the change in breadth 286 and viral load may indicate that a larger breadth is associated with viral control. However, both negative and positive correlations were found in similar proportions, indicating that a greater 288 breadth did not necessarily drive reduction in viral load (or vice versa). To determine if individual 289 epitope-specific CD8 + T cells contribute to viral control, we calculated Spearman's rank correla-290 tion coefficients between the magnitude of epitope-specific T-cell response and viral load for all 291 T-cell responses over time (Fig. 5 ). We found that there were disproportionally more negative 292 than positive correlations, which suggested that increasing T-cell responses drive the decline in 293 viral load ( Fig. 5A ). By dividing the data into correlations during the immune response expansion 294 (t ≤ t peak , Fig. 5B ) and contraction phases (t > t peak , Fig. 5C ) we found that most negative (1)) to the data on the dynamics of epitope-specific CD8 + T-cell response in each patient and plotted the distribution of the estimated parameters. The results are presented separately for T cell responses that started expanding (or contracting) from the first observation ("early" responses, about 80% of all responses; black) or delayed responses, which were undetectable at one or several initial time points ("late" responses; red). Panels show distributions for (A) time of expansion of T-cell response (T on ), (B) time to peak of each T-cell response (T off ), (C) initial predicted frequency of epitope-specific CD8 + T cells (E 0 ), (D, E) expansion (ρ) and contraction (α) rates of T-cell responses, respectively, and (F) proteins recognized by late CD8 + T cell responses. In A-E, n represents the number of fitted responses, and µ, m and σ represent mean, median and standard deviation, respectively (µ 10 , m 10 , and σ 10 are mean, median and standard deviation for log 10 -scaled parameters). Late responses were predicted to have a higher expansion rate ρ (Mann-Whitney, p < 0.001) and smaller frequency E 0 (Mann-Whitney, p < 0.001) than early responses.
Several parameter estimates differed between the two response subsets. In general, early re-316 sponses expanded slower, peaked later, and had a higher predicted frequency E 0 than late responses 317 (Fig. 6 ). The average delay T on in the expansion kinetics of late responses was only 15 days since 318 symptom onset but some responses started expanding even later ( Fig. 6A ). There was a minor 319 difference in the timing of the T-cell response peak (Mann-Whitney, p = 0.035) and over 90% of 320 epitope-specific CD8 + T-cell responses peaked before 100 days since symptom onset (Fig. 6B) .
321
For the early responses, we found that there was an average of 97 antigen-specific CD8 + T cells 322 per million peripheral blood mononuclear cells (PBMC) detected at the first time point (median, 323 13 IFN-γ + spot forming cells (SFC) per million PBMC, Figure 6C ). Note that this is not very 324 different from the experimental estimates of the frequency of human naive CD8 + T cells specific to 325 viral epitopes [87, 99] . To predict a theoretical frequency E 0 at which late responses would start 326 to expand exponentially from t = 0 days since symptom onset, we extended the fitted curve in the 327 negative time direction to estimate the intercept with the y-axis. Around 24% of epitope-specific 328 CD8 + T-cell responses including many "delayed" responses were predicted to have a precursor 329 frequency E 0 < 10 −2 per million PBMC. Because this estimate is physiologically unreasonable 330 [87, 99], many of the "late" responses are likely to have started expanding after the onset of 331 symptoms (i.e., were "delayed").
332
Importantly, the majority (60%) of early epitope-specific CD8 + T cells expanded extremely 333 slowly at a rate of < 0.1 day −1 (median, 0.068 day −1 , Fig. 6D ). An expansion rate of 0. to all T-cell responses in the cohort ( Fig. 2A and Fig. 6F) . A second explanation is that these 350 delayed responses may be actively suppressed by the early responses. To investigate this, we 351 calculated the Pearson correlation coefficients between 20 delayed responses (with a predicted 352 frequency E 0 < 0.01, i.e., T on > 0) and all other responses in these patients; most of these 353 delayed responses were specific to Gag and found predominantly in patient SUMA0874 ( Fig. 2A   354 and Fig. 6F ). Interestingly, only 20% of these correlations were negative, suggesting that other Magnitude of epitope-specific CD8 + T-cell response is likely to be important in limiting virus 366 replication (Fig. 5 ). However, factors that influence the expansion kinetics of the CD8 + T cell 367 response and response peak in humans remain poorly defined. Recent work suggested that viral 368 load in the blood of human volunteers during vaccination is the major determinant of the peak 369 T-cell response following yellow fever virus vaccination [103] . We found that the frequency E 0 had 370 a limited impact on the timing of the T-cell response peak (Fig. 7A ) and the rate of T-cell response 371 expansion strongly affected the timing of the peak (Fig. 7B) . The latter suggests that more rapidly 372 expanding responses peak early, which is markedly different from CD8 + T-cell responses in mice 373 infected with LCMV where T-cell responses, specific to different viral epitopes, expand at different 374 rates but peak at the same time [86, 88, 100, 101] .
375
Interestingly, we found that the expansion rate of epitope-specific T cell responses was strongly 376 dependent on the average viral load during the expansion phase ( Fig. 7C ) and on the estimated 377 frequency E 0 (Fig. 7D ). The dependence of the expansion rate on viral load was nonlinear, in 
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Both the average viral load and predicted frequency E 0 had minimal impact on the peak 389 CD8 + T-cell response (Fig. 7E&F) ; interestingly, no correlation between CD8 + T cell precursor 390 frequency and peak T-cell response was found in mice [105] . The length of the expansion phase 391 (T off − T on ) had little influence on the peak immune response (not shown). It is therefore possible 392 that the peak immune response was determined by virus-independent factors (e.g., cytokines); to depend on viral load (e.g., Fig. 7C&D ). Therefore, for an appropriate comparison of acute and 401 chronic viral infections we calculated the time intervals between the maximum observed viral load 402 and the time when epitope-specific CD8 + T cells were predicted to reach their peak (T off ). About
403
40% of HIV-specific T cells peaked only 10 days after the maximum viremia (not shown). A 10-404 day delay in CD8 + T-cell response peak after the peak viremia is similar to that which has been 405 observed following yellow fever vaccination [60, 61] . Therefore, these results suggest that many 406 HIV-specific CD8 + T-cell responses are generated with similar kinetics relative to viral load for 407 Figure 7 : Correlations between major parameters determining dynamics of HIV-specific CD8 + T-cell responses in acute infection. For all epitope-specific CD8 + T-cell responses in all 22 patients (circles) or the total HIV-specific CD8 + T-cell response per patient (stars), we estimated the initial frequency of epitope-specific CD8 + T cells (E 0 ), rate of expansion of T cell populations (ρ), time of the peak of the response (T off ), rate of contraction of the immune response after the peak (α), predicted peak values reached by the epitope-specific CD8 + T-cell response (E peak = E(T off )), and the average viral load (V E ). Solid lines denote regression lines; regression equations and p values are indicated on individual panels for all epitope-specific CD8 + T-cell responses. The total HIV-specific CD8 + T-cell response showed a similar trend to all epitope-specific CD8 + T-cell responses (results not shown). Panels show correlations between the timing of the immune response peak T off and predicted frequency E 0 (A), T off and ρ (B), expansion rate ρ and average viral load V E (C), ρ and E 0 (D), peak immune response E peak and E 0 (E), and E peak and V E (F). For a given patient, we calculated the total HIV-specific CD8 + T cell response as the sum of all epitope-specific CD8 + T-cell responses at the same time point (i.e., by ignoring "nd"). For patient MM42, we could not fit the T on /T off model to the dynamics of total CD8 + T cell response data because of wide oscillations in the data. Identified relationships did not change if estimates for responses with unphysiological initial frequencies (E 0 ≤ 10 −2 ) were excluded from the analysis (results not shown).
both acute and chronic infections in humans and yet most of them expand significantly slower than Figure 8 : Evidence of interclonal competition between epitope-specific CD8 + T cell responses. We calculated Spearman's rank correlation coefficients between longitudinal changes of pairs of epitopespecific CD8 + T cell responses in a given patient (see individual panels) and plotted the distribution of these coefficients. Panels show the number of correlations (n), fraction of negative correlation coefficients (f (cc) < 0), and p values for the deviance of the distribution from uniform, found using the binomial test with null being the equal fraction of positive and negative correlations. We found that the majority of CD8 + T cell populations expand and contract in unison and therefore do not appear to compete during the infection. Overall, discordant dynamics (negative correlation coefficients) were observed for 18% of all responses irrespective of the stage of infection (acute or chronic). Patients MM38 and MM40 were excluded from the analysis for having too few correlation pairs (two or three).
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that there is no correlation between T-cell response breadth and average size of epitope-specific
453
T-cell response. The two types of analyses (longitudinal in Fig. 8 and cross-sectional in Fig. 9 Figure 9 : Average size of epitope-specific CD8 + T-cell response is unrelated to the number of HIVspecific T-cell responses. For every patient, we calculated the average number of HIV-specific CD8 + T-cell responses and the average density of epitope-specific T cells in a given observation period. To exclude the contribution of viral load to this relationship, we divided all 22 patients into three groups according to their mean viral load (low log 10 viral load: 3. 40-4.44; intermediate viral load: 4.60-5.03; high viral load: 5.25-6.83) . Groups were estimated using the Manhattan Distance with the FindClusters function in Mathematica. Regression lines and corresponding p values are indicated on individual panels. Overall, results varied by time period and most correlations were not statistically significant (Fig. S12 ).
Discussion
458
It is generally accepted that CD8 + T cells play an important role in controlling HIV replication.
459
Features of HIV-specific CD8 + T cell responses that are important in mediating this control remain 460 incompletely understood. T cell specificity, polyfunctionality and ability to proliferate have been 461 cited as important correlates of protection [17, 33, 47, 112] . Here, we analyzed the kinetics of the , mapping was performed twice. Due to missing measurements ("nd") in some epitope-specific CD8 + T cell responses, we estimated the breadth at certain time points for a particular patient in two ways: 1) ignoring the time point (red crosshair ×), or 2) replacing the "nd" with 0 (black dot •) when there was at least one missing measurement at this time point. We found that in some patients (e.g., MM45, MM48, MM49) the breadth expanded slightly to saturation level, and in others, contraction phases followed the saturation (e.g., MM43, MM55). Patient WEAU0575 was followed for 772 days after symptom onset, so the x-axis for this patient is longer. Patients SUMA0874 and MM19 were excluded from this plot due to insufficient measurements of all T-cell responses at all time points. Figure S8 : SE and EI of T-cell responses moderately increased over time. SE and EI were calculated at different time points for all patients (see Material and Methods for more detail); we found a moderate but statistically significant positive trend (Spearman Rank Correlation: ρ = 0.30 (p = 0.00074) and ρ = 0.49 (p 0.0001)). Major significant changes in both measures of breadth occurred within the first 40 days of symptom onset. Analyses included only the time points at which all CD8 + T-cell responses were measured. Detailed SE and EI kinetics in each patient are shown in Figs. S9 and S10, respectively. Figure S11 : Variable correlations between viral load (V) and SE (A-C) or EI (B-F) of Gag-specific CD8 + T-cell responses. Note a positive (but nonsignificant) correlation between viral load and breadth measured by EI, and positive correlation between breadth measured as SE and V for chronic infection (t > 100 days after symptom onset). Figure S13 : Examples of data on the kinetics of eptiope-specific CD8 + T-cell responses and the predicted fits of the basic T on -T off model eqn.
(1) to these data. In all three examples there were no initial zeroes recorded so we set T on = 0 for simplicity. Figure S14 : Examples of strongly negatively (A&C) and strongly positively(B&D) correlated viral load and epitope-specific CD8 + T-cell responses or different epitope-specific CD8 + T-cell responses. The correlation coefficients (ρ) were used to generate the histogram in Figures 5 or 8. Figure S15 : Detailed distributions of correlation coefficient (cc) between different epitope-specific CD8 + T-cell responses (IRs) in different patients for t ≤ 100 days after symptom onset (acute infection). Negatively correlated epitope-specific CD8 + T cell responses were observed for nearly all patients, suggesting that interclonal competition between T cell responses specific to different HIV epitopes may occur in all HIV-infected patients.
